Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective
Gerald F. Watts(Royal Perth Hospital), Trevor A. Mori(The University of Western Australia), John R. Burnett, Elif I. Ekinci(The University of Melbourne), Nadarajah Kangaharan, Damon A. Bell(South Australia Pathology), Gemma A. Figtree(The University of Sydney), J. Andrew Black, Anthony Keech(Heidelberg University), Clara K Chow(Westmead Hospital), Warrick Bishop, Zanfina Ademi(Monash University), Leonard Kritharides(The University of Sydney), Stjepana Maticevic, Lawrence J. Beilin(The University of Western Australia), Jing Pang(The University of Western Australia), Ian Hamilton‐Craig(Griffith University), David L. Hare(The University of Melbourne), Nicola Poplawski(Royal Adelaide Hospital), Stephen CH Li(The University of Western Australia), Karam Kostner(Mater Health Services), Alex Brown(South Australia Pathology), Christian Hamilton‐Craig, B. McQuillan, Clare Heal, Ari Horton(Monash Children’s Hospital), Jacquie Garton‐Smith, Amanda J. Hooper(Fiona Stanley Hospital), Andrew C. Martin(Princess Margaret Hospital for Children), Jodie Ingles, David Sullivan(Royal Prince Alfred Hospital), Andrew B. Kirke, Tom Brett(The University of Notre Dame Australia), Robert Justo, S. Mirzaee, Justin J. Ardill, L. G. Howes, Christina A. Bursill(Australian Research Council), Peter Clifton(Royal Adelaide Hospital), Edward Janus(Deakin University), Alison Colley(Liverpool Hospital), Brett H Forge, Timothy R. Bates, Wendy Barnett, Campbell Kyle, Ronald J. Trent(John Radcliffe Hospital), Dorothy Graham, Paul Lacaze(Australian Regenerative Medicine Institute), Shubha Srinivasan(Children's Hospital at Westmead), Charlotte Hespe
Cited by 8
Related Papers
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k